Anna Morley

5.8k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Anna Morley is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Anna Morley has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 4 papers in Infectious Diseases and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Anna Morley's work include Pleural and Pulmonary Diseases (13 papers), Occupational and environmental lung diseases (11 papers) and Ultrasound in Clinical Applications (3 papers). Anna Morley is often cited by papers focused on Pleural and Pulmonary Diseases (13 papers), Occupational and environmental lung diseases (11 papers) and Ultrasound in Clinical Applications (3 papers). Anna Morley collaborates with scholars based in United Kingdom and United States. Anna Morley's co-authors include Nick Maskell, John Harvey, Clare Hooper, Mike Darby, Anthony Edey, David Arnold, Andrew R L Medford, Duneesha de Fonseka, Amelia Clive and Paul White and has published in prestigious journals such as British Journal of Cancer, European Respiratory Journal and Thorax.

In The Last Decade

Anna Morley

18 papers receiving 1.3k citations

Hit Papers

The Role of CT Pulmonary Angiography in the Investigation... 2013 2026 2017 2021 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Morley United Kingdom 10 714 461 382 249 210 18 1.3k
Mike Darby United Kingdom 6 722 1.0× 308 0.7× 387 1.0× 238 1.0× 199 0.9× 8 1.1k
Andrew Hirsch Canada 14 891 1.2× 340 0.7× 481 1.3× 242 1.0× 356 1.7× 30 1.3k
Anthony Edey United Kingdom 17 718 1.0× 1.1k 2.3× 398 1.0× 461 1.9× 304 1.4× 55 2.0k
Tom van der Hulle Netherlands 19 1.3k 1.8× 240 0.5× 882 2.3× 188 0.8× 265 1.3× 69 1.6k
Arthur Belle France 10 597 0.8× 164 0.4× 212 0.6× 259 1.0× 249 1.2× 51 1.0k
Clare Hooper United Kingdom 15 715 1.0× 1.3k 2.7× 459 1.2× 584 2.3× 400 1.9× 19 2.2k
Renée A. Douma Netherlands 18 1.1k 1.6× 137 0.3× 532 1.4× 283 1.1× 317 1.5× 38 1.4k
Dominique Didier Switzerland 17 822 1.2× 295 0.6× 513 1.3× 322 1.3× 403 1.9× 43 1.4k
Judith Kooiman Netherlands 21 837 1.2× 240 0.5× 797 2.1× 172 0.7× 265 1.3× 46 1.6k
Cornelis J. van Rooden Netherlands 18 615 0.9× 391 0.8× 300 0.8× 73 0.3× 297 1.4× 27 1.2k

Countries citing papers authored by Anna Morley

Since Specialization
Citations

This map shows the geographic impact of Anna Morley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Morley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Morley more than expected).

Fields of papers citing papers by Anna Morley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Morley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Morley. The network helps show where Anna Morley may publish in the future.

Co-authorship network of co-authors of Anna Morley

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Morley. A scholar is included among the top collaborators of Anna Morley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Morley. Anna Morley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morley, Anna, Anthony Edey, Duneesha de Fonseka, et al.. (2025). Serum mesothelin as a response biomarker in pleural mesothelioma. Lung Cancer. 206. 108670–108670. 1 indexed citations
2.
Hyams, Catherine, George Nava, Robert Challen, et al.. (2023). Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults. Journal of the Royal Society of Medicine. 116(11). 371–385. 8 indexed citations
3.
Morley, Anna, William A. Cooper, Anthony Edey, et al.. (2023). Serum mesothelin is a biomarker for disease progression and mortality in mesothelioma. OA1556–OA1556. 3 indexed citations
4.
Arnold, David, Anna Morley, Alice Milne, et al.. (2022). A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial. BMC Pulmonary Medicine. 22(1). 330–330. 5 indexed citations
5.
MacGowan, Alasdair, Fergus Hamilton, Mark Bayliss, et al.. (2021). Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2. Journal of Global Antimicrobial Resistance. 24. 178–179. 3 indexed citations
6.
Arnold, David, Marie Attwood, Shaney Barratt, et al.. (2021). Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study. Emergency Medicine Journal. 38(7). 543–548. 39 indexed citations
7.
Arnold, David, Fergus Hamilton, Tim Morris, et al.. (2020). Epidemiology of pleural empyema in English hospitals and the impact of influenza. European Respiratory Journal. 57(6). 2003546–2003546. 38 indexed citations
8.
Grindell, Cheryl, Angela Tod, Daniel Wolstenholme, et al.. (2020). Using creative co-design to develop a decision support tool for people with malignant pleural effusion. BMC Medical Informatics and Decision Making. 20(1). 179–179. 10 indexed citations
9.
Fonseka, Duneesha de, Anna Morley, Louise Stadon, et al.. (2018). Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial. Trials. 19(1). 467–467. 5 indexed citations
10.
Arnold, David, Duneesha de Fonseka, Anna Morley, et al.. (2018). Investigating unilateral pleural effusions: the role of cytology. European Respiratory Journal. 52(5). 1801254–1801254. 116 indexed citations
11.
Fonseka, Duneesha de, David Arnold, Louise Stadon, et al.. (2018). A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma. BMC Cancer. 18(1). 199–199. 18 indexed citations
12.
Arnold, David, Anna Morley, Paul White, et al.. (2015). The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial. British Journal of Cancer. 112(7). 1183–1189. 21 indexed citations
13.
Hooper, Clare, Iain Lyburn, M. I. Darby, et al.. (2015). The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication. British Journal of Cancer. 112(7). 1175–1182. 44 indexed citations
14.
Arnold, David, Donna Rowen, Matthijs Versteegh, et al.. (2015). Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma. Health and Quality of Life Outcomes. 13(1). 6–6. 19 indexed citations
15.
Hooper, Clare, Anthony Edey, A. Wallis, et al.. (2015). Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal salineversusstandard care in patients with pleural infection. European Respiratory Journal. 46(2). 456–463. 46 indexed citations
16.
Bibby, Anna, Anna Morley, Ioannis Psallidas, et al.. (2014). S117 Survival In Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From 6 Uk Centres. Thorax. 69(Suppl 2). A63–A63. 1 indexed citations
18.
Hooper, Clare, John Harvey, Anna Morley, et al.. (2013). The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions. Respiration. 87(1). 26–31. 941 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026